|
(P1727) |
Cerbral Protection During Transcatheter Heart Valve Implantation Effectively Protects Against Stroke During the Early Peri-Procedural Phase of Intervention |
|
|
F. Deuschl, N. Schofer, B. Vogel, M. Seiffert, C. Frerker, L. Conradi, H. Treede, E. Lubos, J. Schirmer, D. Schewel, K.-H. Kuck, H. Reichenspurner, S. Blankenberg, U. Schäfer (Hamburg) |
|
(P1728) |
Late aortic events after isolated aortic valve replacement for bicuspid aortic valve stenosis and normally sized ascending aorta |
|
|
E. Girdauskas, M. Rouman, K. Disha, A. Espinoza, M.-A. Secknus, B. Lauer, T. Kuntze (Bad Berka) |
|
(P1729) |
Replica sizing improves hemodynamic outcome in aortic valve replacement with conventional tissue valves. |
|
|
D. Gonzalez-Lopez, G. Färber, M. Diab, S. Lemke, P. A. Amorim, N. Zeynalov, M. Breuer, T. Doenst (Jena) |
|
(P1730) |
Stentless bioprostheses for aortic valve replacement: 17-year results |
|
|
J. Ennker, M. Meilwes, J. Pons-Kühnemann, B. Niemann, P. Roth, I. C. Ennker, A. Böning (Lahr/Baden, Gießen) |
|
(P1731) |
New insights in the association between bicuspid aortic valve phenotype, aortic configuration and valve hemodynamics |
|
|
H.-H. Sievers, U. Stierle, R. Hachmann, E. Charitos (Lübeck) |
|
(P1732) |
J-sternotomy vs full sternotomy aortic valve replacement: is there an advantage with the minimally invasive approach? |
|
|
G. Santarpino, J. Sirch, F. Vogt, S. Pfeiffer, T. Fischlein (Nürnberg) |
|
(P1733) |
Vorhofflimmern als unabhängiger prognostischer Prädiktor für die Intrahospitalmortalität bei Patienten mit kathetergestütztem Aortenklappenersatz (TAVI) |
|
|
M. Duckheim, C. Bensch, L. M. Kittlitz, A. Bauer, K. Rizas, C. S. Meyer-Zürn, C. Eick (Tübingen, München) |
|
(P1734) |
Analysis of the additional costs of clinical complications and prediction of cost-outliers in patients undergoing transcatheter aortic valve replacement |
|
|
K. Kaier, A. Gutmann, S. Sorg, C. von zur Mühlen, M. Siepe, M. Moser, A. Geibel-Zehender, A. Zirlik, I. Ahrens, H. Baumbach, F. Beyersdorf, W. Vach, M. Zehender, C. Bode, J. Reinöhl (Freiburg im Breisgau, Bad Krozingen, Stuttgart) |
|
(P1735) |
Significance of aortic valve area at normal transvalvular flow rate (AVAproj) in unmasking pseudo-severe low-flow low-gradient aortic stenosis in patients referred for TAVI procedures |
|
|
U. Fischer-Rasokat, W.-K. Kim, C. Liebetrau, J. Blumenstein, L. Gaede, C. Walther, T. Walther, C. W. Hamm, H. Möllmann (Bad Nauheim) |
|
(P1736) |
Conventional Valve Surgery Without Sternotomy – Challenging the Paradigms |
|
|
G. Färber, K. Gieck, C. Sponholz, M. Diab, T. Doenst (Jena) |
|
(P1737) |
Hemodynamic outcome of the Edwards Sapien 3 Transcather heart valve – Experience in 100 consecutive cases |
|
|
L. Conradi, M. Seiffert, J. Schirmer, E. Lubos, B. Vogel, F. Deuschl, N. Schofer, K. Shimamura, S. Blankenberg, H. Reichenspurner, P. Diemert, H. Treede, U. Schäfer (Hamburg, Heide) |
|
(P1738) |
Reduktion paravalvulärer Klappeninsuffizienzen durch die neue Generation ballonexpandierbarer Aortenklappen unabhängig von der Implantationshöhe: Edwards Sapien 3 versus Sapien/Sapien XT |
|
|
G. Kaleschke, F. De Torres Alba, G. P. Diller, J. Vormbrock, S. Orwat, R. M. Radke, H. Reinecke, H. Baumgartner (Münster) |
|
(P1739) |
Druckgradienten und klinische Ergebnisse der Direct Flow Medical® Transcatheter Aortic Valve |
|
|
S. Tamm, T. Schau, K. Neumann, F. Hölschermann, M. Neuß, D. Bula, C. Butter (Bernau b. Berlin) |